Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy
Introduction. Chemotherapy is a common treatment for breast cancer. Chemotherapeutic drugs effect blood monocytes, which are major contributors to cancer pathogenesis. However, to date, pro-tumor or anti-tumor programming by chemotherapy of monocytes is controversial.Aim. To characterize changes in...
Saved in:
Main Authors: | M. R. Patysheva, M. N. Stakheyeva, E. S. Grigoryeva, P. S. Iamshchikov, I. V. Larionova, А. A. Budnickya, N. A. Tarabanovskaya, N. V. Cherdyntseva, J. G. Kzhyshkowska |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2024-04-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/650 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BLOOD MONOCYTE SUBPOPULATIONS DURING UNCOMPLICATED CORONARY ARTERY BYPASS SURGERY
by: A. S. Golovkin, et al.
Published: (2014-07-01) -
Expression of CD80 and HLA-DR molecules on blood monocytes in patients with pulmonary tuberculosis
by: E. G. Churina, et al.
Published: (2021-11-01) -
Changes in blood monocyte functional profile in breast cancer
by: A. A. Fedorov, et al.
Published: (2023-01-01) -
The Comparison of Monocyte Human Leukocyte Antigen-D-Related (mHLA-DR) Expression Levels Between Corona Virus Disease 2019 (COVID-19) Patients and Healthy Subjects
by: Musholli Himmatun Nabilah, et al.
Published: (2023-03-01) -
Prognostic Value of Peripheral Blood nCD64 Index, mHLA-DR, and CD14+monocyte Percentage in Different Infection Status in COVID-19 Patients
by: Zhu M, et al.
Published: (2025-07-01)